Leukotriene Antagonist News Headlines

• FDA Approves Astellas' Vaprisol(R) For The Treatment Of Hypervolemic Hyponatremia
  MedicalNewsToday - Sat, 03 Mar 2007 08:00 EST
  
• New Link Between Women & Heart Disease
  MedicalNewsToday - Mon, 05 Feb 2007 08:00 EST
  
• New Study Finds Genetic Link Between Women And Heart Disease
  MedicalNewsToday - Sun, 04 Feb 2007 01:00 EST
  
• Study Finds Unexpected Results In Acid Suppression Between Two Top-Selling Widely Used OTC Heartburn Treatments
  MedicalNewsToday - Fri, 12 Jan 2007 08:00 EST
  
• Novel Regulation Of The Common Tumor Suppressor PTEN
  MedicalNewsToday - Fri, 12 Jan 2007 11:00 EST
  
• Novel Regulation Of The Common Tumor Suppressor PTEN
  ScienceDaily - Fri, 12 Jan 2007 04:00 EST
  
• QuatRx Pharmaceuticals Reports Positive Results From A Phase 2 Trial Of Fispemifene
  MedicalNewsToday - Tue, 09 Jan 2007 08:00 EST
  
• Neurocrine Biosciences Announces Initiation Of Phase II Clinical Trials With CRF1 Antagonist For Anxiety And IBS
  MedicalNewsToday - Thu, 21 Dec 2006 08:00 EST
  
• Pfizer Announces Plans To Establish Expanded Access Program For Maraviroc, Investigational HIV CCR5 Antagonist
  MedicalNewsToday - Sat, 02 Dec 2006 08:00 EST
  
• Glenmark's Lead Candidate For Pain, GRC 6211, Enters Phase I In Europe
  MedicalNewsToday - Thu, 14 Dec 2006 08:00 EST
  
• Subsequent Course Of Rituxan® Improved Outcomes In Rheumatoid Arthritis Patients Who Inadequately Responded To Tnf Antagonist Therapy
  MedicalNewsToday - Thu, 23 Nov 2006 08:00 EST
  
• Monogram Provides Update On Trofile(TM) Co-Receptor Tropism Assay
  MedicalNewsToday - Sat, 02 Dec 2006 08:00 EST
  
• Alba Therapeutics Presents Data From Positive Phase Ib Clinical Trial At The XII International Celiac Disease Symposium
  MedicalNewsToday - Tue, 14 Nov 2006 08:00 EST
  
• Neurogen Announces Phase I Clinical Trial For Proprietary Obesity Drug
  MedicalNewsToday - Tue, 14 Nov 2006 08:00 EST
  
• Portola Advances ADP Program: Initiates Phase I Trial With IV Formulation, Trials With Oral Formulation Ongoing
  MedicalNewsToday - Wed, 01 Nov 2006 08:00 EST
  
• Otsuka To Release Oral Vasopressin V2-receptor Antagonist Drug
  MedicalNewsToday - Sat, 14 Oct 2006 07:00 EST
  
• Alba Therapeutics Announces Phase II Trial For Zonulin Antagonist AT-1001
  MedicalNewsToday - Fri, 22 Sep 2006 07:00 EST
  
• Neurocrine Biosciences Announces Results From Follow-Up Phase II Study With Its Orally Active GnRH Receptor Antagonist In Endometriosis
  MedicalNewsToday - Wed, 13 Sep 2006 07:00 EST
  
• Spectrum Pharmaceuticals Announces A License And Collaboration Agreement For Ozarelix With Nippon Kayaku For The Japanese Market
  MedicalNewsToday - Sun, 06 Aug 2006 06:00 EST
  
• Somaxon Pharmaceuticals Reports Positive Results From A Pilot Phase 2 Study Of Oral Nalmefene In Smoking Cessation
  MedicalNewsToday - Thu, 27 Jul 2006 06:00 EST
  
• Positive Results From A Phase IIa Study Of S-2367, A Novel Neuropeptide Y5 Receptor Antagonist For The Treatment Of Obesity
  MedicalNewsToday - Sat, 15 Jul 2006 02:00 EST
  
• Rituxan® Plus Methotrexate Reduced Joint Damage In Rheumatoid Arthritis Patients Who Respond Inadequately To TNF Antagonist Therapies
  MedicalNewsToday - Mon, 26 Jun 2006 06:00 EST
  
• Shionogi Announces Positive Results From A Phase IIa Study Of S-2367, A Novel Neuropeptide Y5 Receptor Antagonist For The Treatment Of Obesity
  MedicalNewsToday - Tue, 11 Jul 2006 06:00 EST
  
• NovaCardia Presents Positive Results Of Two Phase II Trials In Late-Breaking Trials Session At Heart Failure 2006 Congress
  MedicalNewsToday - Tue, 20 Jun 2006 06:00 EST
  
• Sitaxsentan Improves Quality Of Life In Pulmonary Hypertension
  MedicalNewsToday - Fri, 26 May 2006 05:00 EST
  
• Positive Phase II Results With Orally Active GnRH Receptor Antagonist In Endometriosis - Neurocrine Biosciences Inc
  MedicalNewsToday - Sun, 30 Apr 2006 06:00 EST
  
• FDA Grants Fast Track Designation To Schering-Plough For Its Thrombin Receptor Antagonist SCH 530348
  MedicalNewsToday - Thu, 20 Apr 2006 06:00 EST
  
• Higher body weight may curb response to steroid puff
  Reuters - Fri, 10 Mar 2006 03:31 EST
  
• Approval For Orally Disintegrating Formulation Of Amlodin, Hypertension/Angina Pectoris Treatment, Japan
  MedicalNewsToday - Tue, 21 Mar 2006 11:00 EST
  
• HIV, Schering-Plough Provides Update On Phase II Study Of Vicriviroc
  MedicalNewsToday - Sat, 04 Mar 2006 11:00 EST
  
• FDA Approves Rituxan® - The First Targeted B-Cell Therapy For Treatment Of Moderate-To-Severe Rheumatoid Arthritis
  MedicalNewsToday - Sun, 05 Mar 2006 11:00 EST
  
• HIV - Schering-Plough Provides Update On Phase II Study Of Vicriviroc
  MedicalNewsToday - Sun, 05 Mar 2006 11:00 EST
  
• ICS Most Effective For Persistent Asthma In Children
  ScienceDaily - Wed, 11 Jan 2006 03:00 EST
  
• Inhaled Corticosteroids Most Effective For Persistent Asthma In Children
  MedicalNewsToday - Wed, 11 Jan 2006 11:00 EST
  
• FDA Approves Astellas'' Vaprisol® For Treatment Of Euvolemic Hyponatremia
  MedicalNewsToday - Sun, 01 Jan 2006 11:00 EST
  
• GSK nonpeptide oxytocin receptor antagonists damp contractions in late-term rat pregnancy
  MedicalNewsToday - Wed, 20 Jul 2005 03:00 EST
  
• Memantine provides some help in moderate to severe Alzheimer's disease
  MedicalNewsToday - Wed, 20 Apr 2005 04:00 EST